Samsara BioCapital Overview

  • Investor Type

  • Venture Capital

  • Status

  • Active

  • Professionals

  • 10

Professionals
  • Investments

  • 129

  • Portfolio

  • 59

  • Exits

  • 39

Exits

Samsara BioCapital General Information

Description

Founded in 2016, Samsara BioCapital is a venture capital firm based in Palo Alto, California. The firm prefers to invest in the life sciences, oncology, and digital healthcare sectors. The firm provides capital through a company's full risk cycle for private and public companies.

Contact Information

Website
www.samsaracap.com
Year Founded
2016
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 628 Middlefield Road
  • Palo Alto, CA 94301
  • United States
+1 (650) 000-0000

Samsara BioCapital Investments (129)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Upstream Bio 08-Jun-2023 Early Stage VC 00000 Biotechnology Clinical Trials - General 00000000 00000000 00.0
0000000000 24-May-2023 00000 00000 00000 Biotechnology Generating Revenue
000000 00000000000 24-Mar-2023 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2
00000000 06-Mar-2023 00000 00000 0000 Other Devices and Supplies Generating Revenue
000000 22-Feb-2023 0000 00000 Biotechnology Generating Revenue
000000 00000 01-Feb-2023 00000 00000 Therapeutic Devices Clinical Trials - General
00000 000000000000 18-Jan-2023 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1 0000000 000000
00000000 000000000 05-Jan-2023 00000 00000 000.00 Drug Discovery Clinical Trials - General 0000 000000000 00.0
Enlaza Therapeutics 15-Dec-2022 Seed Round 0000 Pharmaceuticals Startup 000000 00000 00.0
Cargo Therapeutics 09-Dec-2022 Early Stage VC 000.00 Drug Discovery Clinical Trials - Phase 1 00000000 00000000 00.0
You’re viewing 10 of 129 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Samsara BioCapital Exits (39)

Company Name Exit Date Exit Type Exit Size
ACELYRIN 05-May-2023 IPO 00000
000000000 10-Feb-2023 000 00000
00000 00000000000 17-Jan-2023 000000000000000000
00000 00000000 20-Oct-2022 000 00000
0000000 20-Sep-2022 000000000000000000 00000
00000000 000000000 01-Jul-2022 000 00 00000000
000000 06-May-2022 000 00000
00000000 29-Apr-2022 000 00000
Nkarta Therapeutics 28-Apr-2022 Public Investment 2nd Offering 00000
Arcellx 04-Feb-2022 IPO 00000
You’re viewing 10 of 39 exits. Get the full list »

Samsara BioCapital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Samsara BioCapital Team (27)

Name Title Deals Funds Boards Office
Miran Ahmad Chief Financial Officer Palo Alto, CA
Srinivas Akkaraju Ph.D Founder & Managing Partner 00 0 00 Palo Alto, CA
David Parry Ph.D Venture Partner & Head of Company Creation 0 Palo Alto, CA
Ravi Rao Ph.D Venture Partner & Head of Company Creation Palo Alto, CA
Gunaretnam Rajagopal Ph.D Venture Partner Palo Alto, CA
You’re viewing 5 of 27 team members. Get the full list »

Samsara BioCapital Co-Investors (321)

Name With Exits Lead Partner Series Industry
Janus Henderson Investors 14 0 0 Series chart Industry bar
Logos Capital 00 0 0 Series chart Industry bar
RA Capital Management 00 0 0 Series chart Industry bar
BVF Partners 00 0 0 Series chart Industry bar
Cormorant Asset Management 00 0 0 Series chart Industry bar
You’re viewing 5 of 321 co-investors. Get the full list »